Fresenius Medical Care (FMS) Competitors $23.08 +0.15 (+0.63%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$23.05 -0.04 (-0.15%) As of 02/21/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FMS vs. NTRA, HIMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, and LFSTShould you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include Natera (NTRA), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Fresenius Medical Care vs. Natera Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Veracyte LifeStance Health Group Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends. Which has better valuation & earnings, NTRA or FMS? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.08B19.79-$434.80M-$1.76-92.22Fresenius Medical Care$21.05B0.64$540.07M$1.2119.08 Does the MarketBeat Community prefer NTRA or FMS? Natera received 61 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 69.04% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes48469.04% Underperform Votes21730.96% Fresenius Medical CareOutperform Votes42354.72% Underperform Votes35045.28% Does the media refer more to NTRA or FMS? In the previous week, Natera had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for Natera and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.56 beat Natera's score of 1.35 indicating that Fresenius Medical Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 10 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals and insiders hold more shares of NTRA or FMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is NTRA or FMS more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Fresenius Medical Care 3.43%6.04%2.69% Do analysts recommend NTRA or FMS? Natera currently has a consensus price target of $170.94, suggesting a potential upside of 5.32%. Fresenius Medical Care has a consensus price target of $25.30, suggesting a potential upside of 9.59%. Given Fresenius Medical Care's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk & volatility, NTRA or FMS? Natera has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. SummaryNatera and Fresenius Medical Care tied by winning 9 of the 18 factors compared between the two stocks. Get Fresenius Medical Care News Delivered to You Automatically Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FMS vs. The Competition Export to ExcelMetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$13.55B$1.94B$5.77B$20.08BDividend Yield1.91%7.61%4.78%3.65%P/E Ratio19.0816.6825.8234.36Price / Sales0.646.99453.6615.65Price / Cash5.029.3044.0520.85Price / Book0.844.547.634.92Net Income$540.07M$87.49M$3.18B$1.02B7 Day Performance-1.58%-2.59%-1.95%-1.05%1 Month Performance-0.41%-6.14%-0.23%-1.09%1 Year Performance18.05%-23.95%16.69%13.70% Fresenius Medical Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FMSFresenius Medical Care3.9964 of 5 stars$23.09+0.6%$25.30+9.6%+19.5%$13.55B$21.05B19.081,358Positive NewsHigh Trading VolumeNTRANatera2.5827 of 5 stars$173.39+1.6%$165.88-4.3%+132.7%$22.89B$1.08B-98.523,293Positive NewsHIMSHims & Hers Health2.645 of 5 stars$60.41+2.1%$25.13-58.4%+422.3%$13.20B$872M137.311,046Analyst DowngradeInsider TradeNews CoverageGap DownHigh Trading VolumeGHGuardant Health4.2446 of 5 stars$48.12+2.4%$42.63-11.4%+89.2%$5.95B$563.95M-11.351,779Earnings ReportAnalyst ForecastNews CoverageGap UpOPCHOption Care Health4.0316 of 5 stars$31.46-1.1%$32.25+2.5%-4.1%$5.35B$4.30B26.447,802Positive NewsRDNTRadNet3.9241 of 5 stars$61.33-1.9%$75.50+23.1%+54.4%$4.54B$1.62B-876.0210,288Positive NewsBTSGBrightSpring Health Services1.8058 of 5 stars$22.05-0.1%$19.42-11.9%+93.7%$3.84B$10.59B-84.8135,000SHCSotera Health2.1641 of 5 stars$13.48+0.4%$16.08+19.3%-17.6%$3.82B$1.05B53.923,000Analyst ForecastNews CoverageNegative NewsSGRYSurgery Partners3.0863 of 5 stars$25.87+0.3%$36.56+41.3%-23.0%$3.29B$2.74B-53.9013,500VCYTVeracyte2.9128 of 5 stars$41.11+3.8%$42.00+2.2%+59.7%$3.19B$361.05M-274.07790Analyst DowngradeNews CoverageLFSTLifeStance Health Group1.5412 of 5 stars$7.97-0.3%$8.70+9.2%+22.0%$3.05B$1.21B-30.659,325Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies NTRA Competitors HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors VCYT Competitors LFST Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:FMS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.